SG Americas Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $766K | Sell |
31,472
-111,816
| -78% | -$2.72M | ﹤0.01% | 1216 |
|
2025
Q1 | $2.98M | Buy |
143,288
+112,201
| +361% | +$2.33M | 0.01% | 588 |
|
2024
Q4 | $732K | Sell |
31,087
-134,679
| -81% | -$3.17M | ﹤0.01% | 898 |
|
2024
Q3 | $4.24M | Buy |
165,766
+36,410
| +28% | +$932K | 0.02% | 414 |
|
2024
Q2 | $3.04M | Buy |
129,356
+6,675
| +5% | +$157K | 0.02% | 714 |
|
2024
Q1 | $3.53M | Sell |
122,681
-90,378
| -42% | -$2.6M | 0.02% | 627 |
|
2023
Q4 | $6.99M | Buy |
213,059
+190,287
| +836% | +$6.24M | 0.07% | 237 |
|
2023
Q3 | $634K | Sell |
22,772
-20,727
| -48% | -$577K | 0.01% | 1460 |
|
2023
Q2 | $1.48M | Sell |
43,499
-12,814
| -23% | -$437K | 0.01% | 794 |
|
2023
Q1 | $1.69M | Buy |
56,313
+11,863
| +27% | +$357K | 0.02% | 697 |
|
2022
Q4 | $1.26M | Buy |
44,450
+6,562
| +17% | +$185K | 0.02% | 714 |
|
2022
Q3 | $1.25M | Buy |
37,888
+7,329
| +24% | +$241K | 0.02% | 735 |
|
2022
Q2 | $962K | Sell |
30,559
-4,887
| -14% | -$154K | 0.01% | 1185 |
|
2022
Q1 | $1.63M | Sell |
35,446
-8,751
| -20% | -$402K | 0.01% | 926 |
|
2021
Q4 | $2.71M | Sell |
44,197
-4,795
| -10% | -$294K | 0.01% | 769 |
|
2021
Q3 | $3.66M | Sell |
48,992
-13,702
| -22% | -$1.02M | 0.02% | 669 |
|
2021
Q2 | $5.8M | Sell |
62,694
-8,410
| -12% | -$778K | 0.03% | 482 |
|
2021
Q1 | $6.31M | Buy |
71,104
+68,052
| +2,230% | +$6.04M | 0.03% | 374 |
|
2020
Q4 | $285K | Buy |
+3,052
| New | +$285K | ﹤0.01% | 2111 |
|
2019
Q2 | – | Sell |
-10,000
| Closed | -$329K | – | 2531 |
|
2019
Q1 | $329K | Buy |
+10,000
| New | +$329K | ﹤0.01% | 1924 |
|